Organized by:

Financial Times Live

Financial Times Live

Asia

+852 2905 5515

ftevents@ft.com

www.live.ft.com

Event Information

The pharmaceutical pricing and market access landscape is being transformed by a host of factors. Value-based pricing is making the transition from concept to reality but more clarity is needed on what it means and how it works for different stakeholders. Revolutionary therapies with innovative pricing models are entering the market but at the same time decision-makers at pharma companies are being asked to defend pricing strategies for established products. Meanwhile, much of the US government's blueprint to lower drug prices is still in the works and yet to be enacted.  

 

The FT Pharma Pricing and Value Summit will explore the future of drug pricing from a balanced perspective. How could the rebate system evolve? Will new powers for Medicare Part D to negotiate drug prices really make a difference to patients?  What global factors could change the pricing and market access landscape in the US?

 

Join us in New York on September 26, 2019 to engage with and learn from the full spectrum of pricing and market access stakeholders including pharma companies, insurers, PBMs, employers, providers and patients.

Venue & Direction

Stewart Hotel

New York, Usa

United States

26 - 26 September, 2019

Event Speakers

Speaker

Speaker

-

Exhibitors Profile

Visitors Profile

•  Pharmaceutical companies
•  Pharmacy benefit managers
•  Medical device manufacturers •  Healthcare providers and insurers
•  Patient representatives and NGOs

Event Partners